Product
Supplier
Encyclopedia
Inquiry
Home > Active Pharmaceutical Ingredients > Digestive System Drugs > Retatrutide for Sale > Retatrutide 30mg vials for weight loss research
Retatrutide 30mg vials for weight loss research buy - large image1
Retatrutide 30mg vials for weight loss research buy - image1
Retatrutide 30mg vials for weight loss research buy - image2
Retatrutide 30mg vials for weight loss research buy - image3
Retatrutide 30mg vials for weight loss research buy - image4
Retatrutide 30mg vials for weight loss research buy - image5
Retatrutide 30mg vials for weight loss research buy - image6

Retatrutide 30mg vials for weight loss research

COA 7485 Inquiries

Unit Price: Get Latest Price
CAS No.:

2381089-83-2

Grade:

Pharmaceutical Grade

Content:

99%

Port:

qingdao

Brand:

JF

Packaging:

10mg,15mg in vial etc

Sample Available:

Yes

Price valid (until):

2025-10-31

Company Type:
Trader
Location:
Hongkong, China
Payment Terms:
TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance
Average Lead Time:
7 days
Qualification:
Main Products:

Weight Loss Peptide,Reta,Tirz,Sema,5 Amino 1mq,Cosmetic raw material,API,SLU-PP-332

  • Product Details

  • Seller Information

  • Inquiry History

  • Description


      Retatrutide 15mg 20mg 30mg vial package for weight loss  


    Name:Retatrutide

    Appearance:raw material powder or lyophilized powder in vial

    Synonym: LY3437943;Retatrutide;GIPR/GLP-1R;Retatrutide/LY3437943/GIPR/GLP-1R;Retaglutide;Retatrutide acetate

    CAS No.2381089-83-2

    Storage conditions: Store at 2-8°C

    Solubility: soluble in DMSO

    Description

    Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insu notropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). Retatrutide inhibits human GCGR, GIPR and GLP-1R with EC50 values of 5.79, 0.0643 and 0.775 nM, respectively and mouse GCGR, GIPR, and GLP-1R with EC50 values of 2.32, 0.191 and 0.794 nM, respectively. It is an important tool for obesity research.Product Detail  

    Items Specifications Test result
    Appearance White powder Conforms
    Purity(HPLC) ≥98.0% 99.30%
    Peptide Content ≥80.0% 92.15%


    Packaging & Shipping

    1.Product packaging: We provide different specifications of packaging according to customer needs, Meet all the needs of customers.
     Different packaging is used for different products.

     2.We can also do private weiboz with aluminum foil bag sealed vacuum packaging. Can provide 5mg 10mg 15mg vial etc

    10vials per box. 

    3.Use high-hardness cartons and filling materials to avoid product damage during transportation.

    Customize service

    We can supply raw material retatrutide powder or lyophilized powdwer wight high and stable quality

    our factory can supply customized service,welcome to contact us if any need.


    Shop Retatrutide 15mg 20mg etc-Detailed Image 1

    Shop Retatrutide in vial package for weight loss-Detailed Image 3

    Shipping

    Fast and safe shipping

    Shop Retatrutide in vial package for weight loss-Detailed Image 4

    our company 


    NATURE INDUSTRIAL LIMITED is a chemical company located in Jinan, Shandong Provincin Hongkong, China. The company was established in 20111 and has since grown to become a leading manufacturer and supplier of pharmaceutical intermediates, APIs, and other fine chemicals.

    Quality is of the utmost importance to us The company has implemented a strict quality control system to ensure that all of its products meet or exceed the highest international standards. The company's quality control department is responsible for testing and analyzing each batch of products to ensure that they are of the highest quality.

    NATURE INDUSTRIAL LIMITED is committed to environmental protection and sustainability. The company has implemented a comprehensive environmental management system that is in compliance with ISO 14001 standards. The company's production processes are designed to minimize waste and reduce the use of energy and other resources.


    We are at exhibitions

    We have established good cooerpation with customers from worldwide.



    ECHEMI Editorial Reference
    Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). Retatrutide inhibits human GCGR, GIPR and GLP-1R with EC50 values of 5.79, 0.0643 and 0.775 nM, respectively and mouse GCGR, GIPR, and GLP-1R with EC50 values of 2.32, 0.191 and 0.794 nM, respectively. It is an important tool for obesity research.Retatrutide potently activates the GLP-1R signaling pathway to stimulate glucose-dependent insulin secretion through activity at the GIP receptor (GIPR) or the GLP-1R.Retatrutide is a synthetic peptide with glucose-lowering effects. It is an antidiabetic agent against type 2 diabetes (T2D), stimulating insulin and suppressing glucagon secretion in a glucose-dependent manner.Retatrutide was also shown to delay gastric emptying, lower fasting and postprandial glucose concentration, decrease food intake and reduce body weight in patients with type 2 diabetes.
    Retatrutide (LY-3437943) was discovered by the American pharmaceutical company Eli Lilly and Company. It is a triple glucagon hormone receptor agonist (GLP-1, GIP, and GCGR receptors) for obesity. The 2024 Lasker~DeBakey Clinical Medical Research Award has been given to Joel Habener and Svetlana Mojsov for their discovery of a new hormone GLP-1(7-37) and to Lotte Knudsen for her role in developing sustained acting versions of this hormone as a treatment for obesity.

    Certificates
    • Retatrutide 30mg vials for weight loss research Certificates 1 COA

    Basic Info
    Product Name:

    Retatrutide

    Other Name:

    Retatrutide;GIPR/GLP-1R;LY3437943Retatrutide;Retalutide;Retatrutide (sodium salt);Retatrutide RT5;retatrutide 5mg;Retatratide

    CAS No.:

    2381089-83-2

    InChIKeys:

    MLOLQJNKXBNWFW-SAGGEDDASA-N

    Molecular Weight:

    0

    EC Number:

    200-001-8

    Color/Form:

    White lyophilized

    Characteristics
    Water Solubility:

    Soluble in water (5mg/ml).

    Storage Conditions:

    -20°C

    Critical Temperature & Pressure:

    -20°C

    Research
    Class:

    Triple agonist — GCGR, GIPR, GLP-1R

    Status:

    Investigational (Phase 3)

    Mechanism:

    Simultaneously activates glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). Engineered from the native GIP backbone with amino acid substitutions to confer GCGR and GLP-1R activity.

    EC50 (Human GCGR):

    5.79 nM

    EC50 (Mouse GIPR):

    0.191 nM

    EC50 (Mouse GLP1R):

    0.794 nM

    EC50 (Mouse GCGR):

    2.32 nM

    EC50 (Human GLP1R):

    0.775 nM

    EC50 (Human GIPR):

    0.0643 nM

    Source:

    Jastreboff AM, et al. N Engl J Med. 2023;389(6):514-526.DOI

    Clinical Development:

    NCT04881760; NCT05882045; NCT06354660

    References
    ChEMBL:

    CHEMBL5095485

    DrugBank:

    DB18993

    KEGG DRUG:

    D12430

    PubChem:

    PubChem

    Disclaimer:

    Retatrutide is an investigational compound not yet approved by FDA or EMA. This listing is for industrial and laboratory research use only. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Weight Loss Peptide,Reta,Tirz,Sema,5 Amino 1mq,Cosmetic raw material,API,SLU-PP-332

    Location:

    Unit D01,3/F., Wong King Industrial Building,No.2 Tai Yau Street, Kowloon

    Payment Terms:

    TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance

    Average lead Time:

    7 days

    Total Annual Revenue:

    $50 million-$100 million

    Total Employees:

    51-100

    Year of Establishment:

    2012

    We have more than 10 years experience in the pharmacy filed. Mainly manufactures pharmaceutical APIs,Pharmaceutical intermediate and Cosmetic raw material. Owing to the good quality and competitive price, we have a very good reputation in China's pharmaceutical circles.

    In the principle of "Quality Oriented", Jianfeng passed the certification of ISO9001:2008 Quality Management System.

    Our products are based on bulk, high volume, wholesale price, third party testing, certificate reporting, and bring high quality ingredients to many domestic and overseas enterprises.

    "Honesty, practicality, innovation, development" are our values. Jianfeng would like to cooperate with you with high quality products and competitive price.

  • Inquiry History
    7485 Inquiries
    Country Product Purchase Quantity Date Posted
    Sweden

    Retatrutide

    10 MG Oct 28, 2026
    United States

    Retatrutide

    1 G Oct 27, 2026
    United Kingdom

    Retatrutide

    10 MG Oct 27, 2026
    Lithuania

    Retatrutide

    30 MG Oct 27, 2026
    United States

    Retatrutide

    10 MG Oct 27, 2026
    Greece

    Retatrutide

    30 MG Oct 27, 2026
    Germany

    Retatrutide

    20 MG Oct 27, 2026
    Canada

    Retatrutide

    30 MG Oct 27, 2026
    United States

    retatrutide

    40 MG Oct 27, 2026
    Spain

    Retatrutide

    30 MG Oct 27, 2026
    United Kingdom

    Retatrutide

    20 MG Oct 27, 2026
    United States

    Retatrutide

    40 MG Oct 27, 2026
    United States

    Retatrutide

    50 MG Oct 27, 2026
    United States

    retatrutide

    30 MG Oct 27, 2026
    United States

    retatrutide

    200 MG Oct 27, 2026
    Spain

    retatrutide

    200 MG Oct 27, 2026
    United States

    Retatrutide

    100 PCS Oct 27, 2026
    New Zealand

    Retatrutide

    20 PCS Oct 27, 2026
    Netherlands

    Retatrutide

    100 20' Fcl Oct 27, 2026
    United States

    Retatrutide

    300 MG Oct 27, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.